Anti-Allergy Medicine Market Forecast Report: Size, Share, and Opportunities 2029

 Use Code ONLINE20 to Save 20% On Global Market Reports — Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

 

 What Is the Estimated Market Size and CAGR of the Anti-Allergy Medicine Market for the Period 2025–2029?
 The anti-allergy medicine market size has grown strongly in recent years. It will grow from $38.84 billion in 2024 to $42.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing prevalence of allergic diseases, growing awareness about allergy treatments, rising adoption of over-the-counter anti-allergy medicines, expansion of healthcare infrastructure, and growing improvements in diagnostic technologies.
 
 The anti-allergy medicine market size is expected to see strong growth in the next few years. It will grow to $58.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing incidence of allergies worldwide, rising demand for fast-acting anti-allergy drugs, growing geriatric population, expansion of online pharmacy channels, and increasing government initiatives for allergy awareness. Major trends in the forecast period include technology advancements in drug delivery systems, innovations in non-sedating antihistamines, developments in personalized allergy treatments, research and development in biologics for allergy, and integration of digital health tools for allergy management.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24463&type=smp
 
 Which Core Drivers Are Expected to Drive Demand Within the Anti-Allergy Medicine Market?
 The growing prevalence of allergies is expected to propel the growth of the anti-allergy medicine market going forward. Allergies refer to hypersensitive immune responses to allergens such as pollen, dust mites, food, or pet dander, causing symptoms ranging from mild irritation to severe, life-threatening reactions. It includes hay fever, asthma, eczema, food allergies, and allergic rhinitis. The growing prevalence of allergies is due to increasing environmental pollution, as pollutants weaken the immune system and heighten sensitivity to common allergens. Anti-allergy medicines help manage allergies by providing targeted relief from allergens, making them essential for individuals with conditions such as hay fever, asthma, and eczema. They reduce immune overreactions by blocking histamines and other triggers, improving daily comfort and quality of life. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of people with asthma rose from 24,963,874 in 2021 to 26,799,588 in 2022. Therefore, the growing prevalence of allergies is driving the growth of the anti-allergy medicine market.
 
 What Are the Primary Market Segments in the Anti-Allergy Medicine Market?
 The anti-allergy medicine market covered in this report is segmented — 
 
 1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Leukotriene Inhibitors, Mast Cell Stabilizers, Other Drug Classes
 2) By Type Of Allergy: Seasonal Allergies, Perennial Allergies, Food Allergies, Skin Allergies, Insect Sting Allergies
 3) By Formulation: Tablets, Capsules, Syrups, Nasal Sprays, Eye Drops, Injectables
 4) By Application: Online Pharmacy, Hospital, Offline Pharmacy, Clinic, Other Applications
 5) By End User: Children, Adults, Geriatric Population, Pregnant Women
 
 Subsegments:
 1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines, Third-Generation Antihistamines
 2) By Corticosteroids: Oral Corticosteroids, Nasal Corticosteroids, Inhaled Corticosteroids, Topical Corticosteroids
 3) By Decongestants: Oral Decongestants, Nasal Spray Decongestants, Topical Decongestants
 4) By Leukotriene Inhibitors: Leukotriene Receptor Antagonists, Leukotriene Synthesis Inhibitors
 5) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil Sodium
 6) By Other Drug Classes: Immunotherapy Agents, Biologics, Monoclonal Antibodies
 
 What Are the Key Industry Trends Driving Growth in the Anti-Allergy Medicine Market?
 Major companies operating in the anti-allergy medicine market are focusing on developing innovative therapies and getting approvals, such as monoclonal antibody therapies, to provide targeted treatment, improve efficacy, reduce side effects, and address chronic and severe allergic conditions. Monoclonal antibody therapies refer to laboratory-made proteins that mimic the immune system’s ability to fight harmful allergens by specifically targeting and blocking immune pathways involved in allergic reactions, offering precise and long-lasting relief. For instance, in December 2024, Galderma SA, a Switzerland-based pharmaceutical company, received approval from the Food and Drug Administration (FDA) for Nemluvio (nemolizumab-ilto) for the treatment of adults and pediatric patients 12 years of age and older with moderate to severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors. This monoclonal antibody is an interleukin-31 receptor antagonist that works by blocking IL-31 signaling, a key driver of inflammation and itch in atopic dermatitis, thereby reducing symptoms and improving skin condition.
 
 Who Are the Major Companies Operating in the Anti-Allergy Medicine Market?
 Major companies operating in the anti-allergy medicine market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Perrigo Company plc, Cipla Limited, Dr. Reddy’s Laboratories, Lupin Limited, Zydus Lifesciences Limited, Takeda Pharmaceutical Company Limited, Torrent Pharmaceuticals Ltd., ALK-Abelló A/S, Torii Pharmaceutical Co. Ltd., Biomay Aktiengesellschaft, Kaléo Inc., Immunomic Therapeutics Inc., Circassia Group plc, Sun Pharmaceutical Industries Ltd., Anergis S.A., Aravax Pty Ltd., DBV Technologies S.A., Desentum Oy. 
 
 Get the detailed anti-allergy medicine market report today
 https://www.thebusinessresearchcompany.com/report/anti-allergy-medicine-global-market-report
 
 Which Region Holds the Largest Share of the Anti-Allergy Medicine Market?
 North America was the largest region in the anti-allergy medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-allergy medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company